Helei Hou

5PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 08, 2026
Efficacy and safety of neoadjuvant treatment with chemotherapy and immune checkpoint blockades for potentially resectable gastric cancer: A retrospective study.

Huiyun Wang, Xuchen Zhang, Yulong Tian

|Dec 05, 2025
A case report: Achieving complete response in synchronous primary lung and tongue squamous cell carcinomas through the integration of albumin-bound paclitaxel, cisplatin, and tislelizumab.

Xiao Huang, Ying Ma, Huiyun Wang

|Sep 09, 2025
Next-generation sequencing identifies potential mechanisms of primary resistance to trastuzumab-containing therapies in HER2-positive gastric cancer: Analysis based on real-world data and online databases.

Xuchen Zhang, Ning Liu, Shanai Song

|Sep 23, 2022
Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification.

Dantong Sun, Junyan Tao, Weihua Yan

|Oct 16, 2020
Advancement in research and therapy of NF1 mutant malignant tumors.

Junyan Tao, Dantong Sun, Lina Dong

Pageof 1

Frequent Collaborators